The Impact of Obstructive Sleep Apnea on Metabolic and Inflammatory Markers in Consecutive Patients with Metabolic SyndromeReportar como inadecuado

The Impact of Obstructive Sleep Apnea on Metabolic and Inflammatory Markers in Consecutive Patients with Metabolic Syndrome - Descarga este documento en PDF. Documentación en PDF para descargar gratis. Disponible también para leer online.


Obstructive Sleep Apnea OSA is tightly linked to some components of Metabolic Syndrome MetS. However, most of the evidence evaluated individual components of the MetS or patients with a diagnosis of OSA that were referred for sleep studies due to sleep complaints. Therefore, it is not clear whether OSA exacerbates the metabolic abnormalities in a representative sample of patients with MetS.

Methodology-Principal Findings

We studied 152 consecutive patients age 48±9 years, body mass index 32.3±3.4 Kg-m2 newly diagnosed with MetS Adult Treatment Panel III. All participants underwent standard polysomnography irrespective of sleep complaints, and laboratory measurements glucose, lipid profile, uric acid and C-reactive protein. The prevalence of OSA apnea-hypopnea index ≥15 events per hour of sleep was 60.5%. Patients with OSA exhibited significantly higher levels of blood pressure, glucose, triglycerides, cholesterol, LDL, cholesterol-HDL ratio, triglycerides-HDL ratio, uric acid and C-reactive protein than patients without OSA. OSA was independently associated with 2 MetS criteria: triglycerides: OR: 3.26 1.47–7.21 and glucose: OR: 2.31 1.12–4.80. OSA was also independently associated with increased cholesterol-HDL ratio: OR: 2.38 1.08–5.24, uric acid: OR: 4.19 1.70–10.35 and C-reactive protein: OR: 6.10 2.64–14.11. Indices of sleep apnea severity, apnea-hypopnea index and minimum oxygen saturation, were independently associated with increased levels of triglycerides, glucose as well as cholesterol-HDL ratio, uric acid and C-reactive protein. Excessive daytime sleepiness had no effect on the metabolic and inflammatory parameters.


Unrecognized OSA is common in consecutive patients with MetS. OSA may contribute to metabolic dysregulation and systemic inflammation in patients with MetS, regardless of symptoms of daytime sleepiness.

Autor: Luciano F. Drager , Heno F. Lopes, Cristiane Maki-Nunes, Ivani C. Trombetta, Edgar Toschi-Dias, Maria Janieire N. N. Alves, Raffa



Documentos relacionados